Funding Opportunities Specific to COVID-19
The Office of the Vice President for Research is pleased to announce the following funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
NOTE : Many new funders have emerged in response to the global COVID-19 crisis, some without a prior history of working with MIT. The opportunities below may have terms or conditions that need to be addressed before funds can be accepted. As with any funding source, be sure to work with your DLC fiscal officer and associated RAS staff to ensure that you are aware of and can meet all the requirements, which may include items such as indirect cost under recovery, IP considerations, reporting or data sharing.
Last updated July 1, 2020.
|COVID-19 / Coronavirus Resources||InfoEd Global||The SPIN funding opportunities database contains nearly 40,000 government, foundation, and industry sponsored funding opportunities, including nearly 200 specific to COVID-19.||
|NSF COVID-19 Resources Page||National Science Foundation (NSF)||Funding Opportunities and FAQs on NSF COVID-19 research including activities under existing awards.||N/A|
|NIH COVID-19 Funding Information Page||National Institutes of Health (NIH)||COVID-19 Information for NIH research Funding||N/A|
|Submit research ideas for accessible coronavirus treatments here||COVID Therapeutics Accelerator||The COVID-19 Therapeutics Accelerator is a collaborative effort to research, develop and bring effective treatments to market quickly and accessibly. Initial funding of $125M from Gates, Wellcome & Mastercard||Ongoing|
|Luminary Labs Open Innovation Challenges: Novel approaches to COVID-19 testing||Luminary Labs||Luminary Labs are tracking 165+ COVID-19 open innovation initiatives to address the coronavirus pandemic||
|Office of Management and Budget (OMB)||White House / OMB||Implementation Guidance for Supplemental Funding Provided in Response to the Coronavirus Disease 2019 (COVID-19)||Informational Notice|
|Research Grant for Pandemic Preparedness||Merck KGaA||Proposals will be considered that leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections.||August 21, 2020|
|CSO_COVID_19 Response||Department of the Air Force (DOD/DAF)||Air Force Acquisition COVID-19 Task Force (DAF ACT) Support innovative technologies to provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic||
Open until Sept 30, 2020
|XSEDE COVID-19 HPC Consortium||DOE ASCR, DOE NNSA, RPI, MIT/MGHPCC, IBM, NSF, NASA HECC, Amazon AWS, Microsoft Azure HPC, HP Enterprise, Google||The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.||Ongoing|
|Seeking Input and Collaboration on Science and Technology Response to COVID-19||Department of Energy (DOE)||
The DOE encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Please send research questions to SC.DCL@science.doe.go
|Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19
|National Science Foundation (NSF)||The National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. Dedicated email address to inquire about the program:firstname.lastname@example.org||Ongoing|
|Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)||DoD||Advanced Manufacturing Technologies, Ventilators, Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection)||October 31, 2020|
|DARPA Broad Agency Announcements (BAAs)||DoD||Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time in technology development, biomedical, and engineering disciplines.||Ongoing|
|U.S. Air Force COVID-19 Ventillator Challenge||DoD||Innovative technologies that propose new solutions and/or potentially new capabilities in support of the COVID-19 Response Acquisition Task Force (DAF ACT)||September 30, 2020|
|IARPA COVID-19 Seedling Research Topics||DoD||Technology development, Physical Sciences, Computation||July 7, 2020|
|Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)||NIH||Development, translation, and commercialization of technologies to address COVID-19; develop life-saving technologies that can be ready for commercialization within one to two years.||November 10, 2020|
|data.org Inclusive Growth and Recovery Challenge||Private/Foundation||An open call for breakthrough ideas in social sciences, public health, and computation that harness the power of data science to help people and communities thrive in the wake of COVID-19’s economic impact.||July 17, 2020|